Aiforia Technologies Plc - Managers' Transactions
Aiforia Technologies Plc, Company release, Managers’ Transactions, May 24, 2024 12:00 p.m. EEST
Aiforia Technologies Plc - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: TJT Technologies Oy
Position: Chief Executive Officer
(X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer
Name: Tuomas Tenkanen
Position: Member of the Board
Issuer: Aiforia Technologies Plc
LEI: 743700TJRVBX7420Y723
Notification type: INITIAL NOTIFICATION
Reference number: 63952/8/8
____________________________________________
Transaction date: 2024-05-23
Outside a trading venue
Instrument type: SHARE
ISIN: FI4000507934
Nature of transaction: SUBSCRIPTION
Transaction details
(1): Volume: 28571 Unit price: 3.5 EUR
Aggregated transactions (1):
Volume: 28571 Volume weighted average price: 3.5 EUR
Further inquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc
tel. +358405009878
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.
Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.
Find out more at www.aiforia.com